ARMISTICE CAPITAL, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001601086

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q1 2026 · 253 positions · Total reported value $5.05B · Top-10 concentration 59.1% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 80.3% · 158 new · 82 cut · 148 exited

Active Share (vs S&P 500): 94.8% · vs QQQ: 95.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -2.0% · vs SPY -4.1% · Prev Value $7.59B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +0.3% · vs SPY -1.9% · Latest Value $7.32B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2026 13F filing, ARMISTICE CAPITAL, LLC disclosed 253 equity positions with a combined reported value of $5.05B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 59.1% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2026 were SPY ($1.37B), IWM ($868.00M), TVTX ($145.50M). By sector, the heaviest allocations are Health Care 36.4%, Technology 8.3%. Versus the prior quarter, allocation shifted toward Health Care (+5.6pp), Technology (+1.5pp) and away from Consumer Discretionary (-1.6pp), Other (-5.7pp).

Versus the prior quarter, ARMISTICE CAPITAL, LLC opened 158 new positions, trimmed 82 and fully exited 148, a turnover rate of 80.3% of positions. The portfolio's overlap with the prior quarter was 34% of names.

The largest new positions opened in Q1 2026 were UNH ($40.05M), META ($18.65M), CENTA ($15.50M).

Of the 148 positions fully exited versus the prior quarter, the largest were ARGX ($48.78M), SBUX ($46.30M), MDT ($26.06M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q1 2026)

  • UNH UNITEDHEALTH GROUP INC · $40.05M
  • META META PLATFORMS INC · $18.65M
  • CENTA CENTRAL GARDEN & PET CO · $15.50M
  • CPRI CAPRI HOLDINGS LIMITED · $11.59M
  • XERS XERIS BIOPHARMA HOLDINGS INC · $11.08M
  • ESPR ESPERION THERAPEUTICS INC NE · $10.77M
  • IQV IQVIA HLDGS INC · $10.38M
  • SGMOQ SANGAMO THERAPEUTICS INC · $9.97M

Fully Exited (vs previous quarter)

  • ARGX ARGENX SE · prev qtr: $48.78M
  • SBUX STARBUCKS CORP · prev qtr: $46.30M
  • MDT MEDTRONIC PLC · prev qtr: $26.06M
  • DHR DANAHER CORP DEL · prev qtr: $24.50M
  • CVS CVS HEALTH CORP · prev qtr: $23.46M
  • DXCM DEXCOM INC · prev qtr: $21.44M
  • LYV LIVE NATION ENTERTAINMENT IN · prev qtr: $17.23M
  • NVO NOVO-NORDISK A S · prev qtr: $17.10M

Insider Transactions (Form 4)

Latest ARMISTICE CAPITAL, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Armistice Capital is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 325 US equity positions with a combined value of $7.59B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-100464 (status: Approved), registered 2015-07-02
  • Regulatory AUM (Form ADV): $4.72B as of 2026-03-31
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 1 private funds, of which 1 hedge funds
  • Website: armisticecapital.com

Portfolio Structure

  • 325 positions · $7.59B reported value (Q2 2026)
  • Top 10 holdings = 65.2% of reported value
  • Largest position: SPY (STATE STR SPDR S&P 500 ETF T) at 31.5%
  • Average position size: $23.35M

Sector Tilt

  • Health Care 29.3%
  • Information Technology 7.4%
  • Consumer Discretionary 5.2%
  • (classified holdings cover 45% of value)

Quarterly Activity

  • Q2 2026: 168 new, 72 added, 65 reduced, 96 exited
  • 20 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 36.4%
Technology 8.3%
Energy 0.1%
Other 46.2%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 2.10M $1.37B 27.04%
27.04%
Reduce
2 3.50M $868.00M 17.18%
17.18%
Reduce
3 4.90M $145.50M 2.88%
2.88%
Add
4 264.58K $138.50M 2.74%
2.74%
Hold
5 1.90M $97.97M 1.94%
1.94%
Reduce
6 724.00K $95.38M 1.89%
1.89%
Reduce
7 2.72M $91.88M 1.82%
1.82%
Reduce
8 1.09M $64.46M 1.28%
1.28%
Reduce
9 656.82K $61.82M 1.22%
1.22%
Reduce
10 3.18M $57.56M 1.14%
1.14%
Reduce
11 262.14K $54.60M 1.08%
1.08%
Reduce
12 15.03M $52.75M 1.04%
1.04%
Reduce
13 1.90M $47.20M 0.93%
0.93%
Add
14 1.62M $45.49M 0.90%
0.90%
Add
15 91.49K $44.97M 0.89%
0.89%
Add
16 578.00K $41.59M 0.82%
0.82%
Reduce
17 148.00K $40.05M 0.79%
0.79%
New
18 518.76K $37.31M 0.74%
0.74%
Add
19 1.19M $35.82M 0.71%
0.71%
Add
20 3.00M $34.80M 0.69%
0.69%
Reduce
21 1.28M $34.61M 0.69%
0.69%
Add
22 536.00K $34.27M 0.68%
0.68%
Add
23 118.51K $34.08M 0.68%
0.68%
Reduce
24 1.18M $31.86M 0.63%
0.63%
Add
25 128.58K $31.39M 0.62%
0.62%
Add
26 936.00K $31.01M 0.61%
0.61%
Hold
27 2.70M $30.97M 0.61%
0.61%
Add
28 3.74M $30.37M 0.60%
0.60%
Reduce
29 2.00M $28.02M 0.56%
0.56%
Reduce
30 36.13K $27.91M 0.55%
0.55%
Reduce
31 157.96K $27.08M 0.54%
0.54%
Add
32 390.00K $26.57M 0.53%
0.53%
Reduce
33 107.30K $26.26M 0.52%
0.52%
Add
34 204.00K $25.59M 0.51%
0.51%
Reduce
35 564.86K $25.14M 0.50%
0.50%
Add
36 1.24M $24.88M 0.49%
0.49%
Add
37 208.56K $24.62M 0.49%
0.49%
Reduce
38 141.28K $24.50M 0.48%
0.48%
Add
39 4.59M $24.34M 0.48%
0.48%
Add
40 52.04K $23.99M 0.47%
0.47%
Reduce
41 2.99M $23.96M 0.47%
0.47%
Add
42 3.20M $23.04M 0.46%
0.46%
Add
43 1.03M $22.26M 0.44%
0.44%
Add
44 15.80M $21.80M 0.43%
0.43%
Reduce
45 1.65M $21.25M 0.42%
0.42%
Reduce
46 1.87M $21.25M 0.42%
0.42%
Add
47 1.98M $20.97M 0.41%
0.41%
Add
48 61.25K $20.70M 0.41%
0.41%
Add
49 912.00K $20.50M 0.41%
0.41%
Reduce
50 1.20M $19.70M 0.39%
0.39%
Add

FAQ

What did ARMISTICE CAPITAL, LLC buy in 2026-Q1?

In its 2026-Q1 13F filing, ARMISTICE CAPITAL, LLC reported 253 equity positions worth $5.05B in aggregate; its largest disclosed positions were SPY ($1.37B), IWM ($868.00M), TVTX ($145.50M).

How large is ARMISTICE CAPITAL, LLC's portfolio?

ARMISTICE CAPITAL, LLC reported $5.05B of long equity holdings across 253 positions as of 2026-Q1. Top-10 holdings account for 59.1% of reported value.

What is ARMISTICE CAPITAL, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/armistice-capital/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →